Abstract
Assessing pre-exposure prophylaxis (PrEP) coverage and identifying reasons for disproportionate uptake among the varied social and cultural sub-groups of men who have sex with men (MSM) and transgender women who have sex with men (TWSM) are necessary precursors to setting attainable local PrEP. We report on findings of a cross-sectional survey among MSM/TWSM attending Gay pride events in Atlanta, Georgia, in 2018. Associations between PrEP awareness, uptake, and respondent characteristics were assessed using logistic regression. PrEP awareness did not differ by race, but current use was significantly lower among Blacks at substantial risk of HIV (p = .008). In multivariate analysis, clinician encounter in the past year was associated with awareness while age, income, drug use, sero-discordant sex, and multiple male partners were associated with current use. Among PrEP-naïve MSM/TWSM, the most common reasons for nonuse differed by race (poor knowledge of PrEP: Black—45% vs. non-Black—27%, p = .010, low perception of risk: Black—26% vs. non-Black—52%, p = .001). Key racial and socioeconomic disparities in active PrEP use and reasons for nonuse remain despite the recent increases in PrEP awareness and use among MSM/TWSM in Atlanta. Achieving overall improvement in uptake among all MSM/TWSM sub-groups will require tailoring PrEP educational messaging, optimizing communication modalities, expanding provider outreach, and identifying ways to defray costs for high-risk, underserved sub-groups in these populations.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
AIDSVu. (2018). Deeper look: PrEP—AIDSVu. Retrieved September 20, 2019, from https://aidsvu.org/resources/deeper-look-prep/.
AIDSVu. (2019). AIDSVu: Local data—Atlanta. Retrieved September 20, 2019, from https://aidsvu.org/local-data/united-states/south/georgia/atlanta/.
Barrientos, J., Silva, J. L., Catalan, S., Gomez, F., & Longueira, J. (2010). Discrimination and victimization: Parade for lesbian, gay, bisexual, and transgender (LGBT) Pride, Chile. Journal of Homosexuality,57(6), 760–775.
Centers for Disease Control and Prevention (CDC). (2017). Preexposure prophylaxis for the prevention of HIV infection in the United States (2017 update). Retrieved September 25, 2019, from https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2017.pdf.
Centers for Disease Control and Prevention (CDC). (2020). HIV and transgender people. Retrieved February 22, 2020, from https://www.cdc.gov/hiv/group/gender/transgender/index.html.
Cooley, L. A., Oster, A. M., Rose, C. E., Wejnert, C., Le, B. C., Paz-Bailey, G., & The NHBS Study Group. (2014). Increases in HIV testing among men who have sex with men—National HIV behavioral surveillance system, 20 US metropolitan statistical areas, 2008 and 2011. PLoS One, 9(9). https://doi.org/10.1371/journal.pone.0104162.
Dubov, A., Galbo, P., Altice, F. L., & Fraenkel, L. (2018). Stigma and shame experiences by MSM who take PrEP for HIV prevention: A qualitative study. American Journal of Men’s Health,12(6), 1843–1854. https://doi.org/10.1177/1557988318797437.
Eaton, L. A., Matthews, D. D., Driffin, D. D., Bukowski, L., Wilson, P. A., Stall, R. D., et al. (2017). A multi-US city assessment of awareness and uptake of pre-exposure prophylaxis (PrEP) for HIV prevention among black men and transgender women who have sex with men. Prevention Science,18(5), 505–516. https://doi.org/10.1007/s11121-017-0756-6.
Fauci, A. S., Redfield, R. R., Sigounas, G., Weahkee, M. D., & Giroir, B. P. (2019). Ending the HIV epidemic: A plan for the United States. Journal of the American Medical Association,321(9), 844–845. https://doi.org/10.1001/jama.2019.1343.
Finlayson, T., Cha, S., Xia, M., Trujillo, L., Denson, D., Prejean, J., et al. (2019). Changes in HIV preexposure prophylaxis awareness and use among men who have sex with men—20 urban areas, 2014 and 2017. Morbidity and Mortality Weekly Report,68(27), 597–603. https://doi.org/10.15585/mmwr.mm6827a1.
Fulton County Board of Health, STOPHIVATL. (2018). STOPHIVATL. Retrieved August 29, 2019, from https://stophivatl.org/.
Georgia Department of Public Health. (2019). HIV surveillance summary Georgia, 2017. Atlanta: Georgia Department of Public Health.
Grey, J. A., Bernstein, K. T., Sullivan, P. S., Purcell, D. W., Chesson, H. W., Gift, T. L., & Rosenberg, E. S. (2016). Estimating the population sizes of men who have sex with men in US states and counties using data from the american community survey. JMIR Public Health and Surveillance,2(1), e14. https://doi.org/10.2196/publichealth.5365.
Hoots, B. E., Finlayson, T., Nerlander, L., & Paz-Bailey, G. (2016). Willingness to take, use of, and indications for pre-exposure prophylaxis among men who have sex with men—20 US cities, 2014. Clinical Infectious Diseases,63(5), 672–677. https://doi.org/10.1093/cid/ciw367.
Huang, Y. A., Zhu, W., Smith, D. K., Harris, N., & Hoover, K. W. (2018). HIV preexposure prophylaxis, by race and ethnicity—United States, 2014–2016. Morbidity and Mortality Weekly Report,67(41), 1147–1150. https://doi.org/10.15585/mmwr.mm6741a3.
Iniesta, C., Álvarez-Del Arco, D., García-Sousa, L. M., Alejos, B., Díaz, A., Sanz, N., et al. (2018). Awareness, knowledge, use, willingness to use and need of pre-exposure prophylaxis (PrEP) during World Gay Pride 2017. PLoS ONE,13(10), e0204738. https://doi.org/10.1371/journal.pone.0204738.
Jenness, S. M., Goodreau, S. M., Rosenberg, E., Beylerian, E. N., Hoover, K. W., Smith, D. K., et al. (2016). Impact of the centers for disease control’s HIV preexposure prophylaxis guidelines for men who have sex with men in the United States. Journal of Infectious Diseases,214(12), 1800–1807. https://doi.org/10.1093/infdis/jiw223.
Kelley, C. F., Kahle, E., Siegler, A., Sanchez, T., Del Rio, C., Sullivan, P. S., et al. (2015). Applying a PrEP continuum of care for men who have sex with men in Atlanta, Georgia. Clinical Infectious Diseases,61(10), 1590–1597. https://doi.org/10.1093/cid/civ664.
Myers, J. E., Braunstein, S. L., Xia, Q., Scanlin, K., Edelstein, Z., Harriman, G., et al. (2018). Redefining prevention and care: A status-neutral approach to HIV. Open Forum Infectious Diseases, 5(6). https://doi.org/10.1093/ofid/ofy097.
Rolle, C. P., Onwubiko, U. N., Jo, J., Sheth, A. N., Kelley, C. F., & Holland, D. P. (2019). PrEP implementation and persistence in a county health department setting in Atlanta, GA. AIDS and Behavior, 23(Suppl. 3), 296–303. https://doi.org/10.1007/s10461-019-02654-x.
Rolle, C. P., Rosenberg, E. S., Siegler, A. J., Sanchez, T. H., Luisi, N., Weiss, K., et al. (2017). Challenges in translating PrEP interest into uptake in an observational study of young black MSM. Journal of Acquired Immune Deficiency Syndromes,76, 250–258. https://doi.org/10.1097/qai.0000000000001497.
Storholm, E. D., Fisher, D. G., Reynolds, G. L., Napper, L. E., Morrisse, T. A., & Kochems, L. M. (2010). Hepatitis vaccination of men who have sex with men at gay pride events. Prevention Science,11(2), 219–227. https://doi.org/10.1007/s11121-009-0164-7.
Sullivan, P. S., Giler, R. M., Mouhanna, F., Pembleton, E. S., Guest, J. L., Jones, J., et al. (2018). Trends in the use of oral emtricitabine/tenofovir disoproxil fumarate for pre-exposure prophylaxis against HIV infection, United States, 2012–2017. Annals of Epidemiology,28(12), 833–840. https://doi.org/10.1016/j.annepidem.2018.06.009.
US Department of Health and Human Services. (2019). Statement on FY2020 budget proposal for ending the HIV epidemic in America. HHS.gov. Retrieved September 18, 2019, from https://www.hhs.gov/about/news/2019/03/11/statement-on-fy2020-budget-proposal-for-ending-the-hiv-epidemic-in-america.html.
Wu, H., Mendoza, M. C., Huang, Y. A., Hayes, T., Smith, D. K., & Hoover, K. W. (2017). Uptake of HIV preexposure prophylaxis among commercially insured persons-United States, 2010–2014. Clinical Infectious Diseases,64(2), 144–149. https://doi.org/10.1093/cid/ciw701.
Acknowledgements
This work was assisted in part by a developmental grant from the NIH Center for AIDS Research (CFAR) at Emory University (P30AI050409). We also acknowledge all Sexual Health Promotion staff at Fulton County Board of Health, the #STOPHIVATL team, the Fulton County HIV/AIDS Advisory committee, the Georgia Department of Public Health and all Board of Health-affiliated community-based organizations for their spirited contributions toward ending the HIV epidemic in Fulton County and the City of Atlanta, Georgia.
Funding
This work was assisted in part by a developmental Grant from the NIH Center for AIDS Research (CFAR) at Emory University (P30AI050409).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Author ATC received a developmental grant from the NIH Center for AIDS Research (CFAR) at Emory University (P30AI050409) in August 2018 for the purpose of this study. All other authors have no conflict of interest to declare.
Ethical Approval
The study protocol and survey instrument used in this study were reviewed and approved by the institutional review boards (IRB) of the Georgia Department of Public Health (Project #:180602) and Emory University.
Informed Consent
Survey data collection was completely anonymous, and the requirement for written informed consent was waived by both IRBs. Verbal consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Onwubiko, U., Holland, D., Ajoku, S. et al. Using PrEP to #STOPHIVATL: Findings from a Cross-Sectional Survey Among Gay Men and Transgender Women Participating in Gay Pride Events in Atlanta, Georgia, 2018. Arch Sex Behav 49, 2193–2204 (2020). https://doi.org/10.1007/s10508-020-01711-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10508-020-01711-0